Clinical Trial Update: L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for L-NMMA plus taxane chemotherapy in refractory locally advanced or metastatic triple-negative breast cancer (Phase 1/Phase 2; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• L-NMMA (NG-monomethyl-L-arginine)
• taxane chemotherapy (taxane)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Metastatic Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-15